NCT04222114
Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 6, 2020
Completion: Aug 31, 2023